Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine spray with or without PowerIce Deltazax cooling spray for pain reduction during venous catheterization
IRCT20200707048047N3Phase 3Completed
- Sponsor
- Islamic Azad University
- Start
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of lidocaine (2 arms), sponsored by Islamic Azad University. Primary endpoints: Pain intensity and Heart rate increase. Started Feb 2023; status: completed.
02
Drugs
lidocaine
Beyond the preview
Go deeper on IRCT20200707048047N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200707048047N3.